Associate at BioGeneration Ventures
Check size: BGV does not publish a standard current startup check-size range on its official site.
The official roster identifies Karen Chan as Associate. This profile applies BioGeneration Ventures's published strategy and does not infer undisclosed personal signing authority or a narrower individual mandate. Relevant founder fit follows the firm's thesis: Lead early investments and help shape European biotechnology companies addressing serious unmet medical needs.
Lead with founder-market fit, the specific problem, differentiated product or technology, evidence of demand, market size, round stage and why the opportunity matches BioGeneration Ventures's published focus. Address the role of Associate without assuming individual check authority.
At firm level, BioGeneration Ventures is aligned with lead early investments and help shape European biotechnology companies addressing serious unmet medical needs. This is firm-level guidance, not an invented personal preference.
No personal pass list is public. Opportunities outside BioGeneration Ventures's stated stages, sectors, geography or team criteria should be treated as lower fit rather than a confirmed personal rejection rule.